View allAll Photos Tagged Brainstorming
019
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
7:45 AM
CONCURRENT BREAKFAST SOLUTION SESSIONS
HOTTEST HEALTH CARE INVESTMENTS OF 2018
A record $5.8 billion poured into digital health care companies in 2017, and yet most signs suggest this revolution is just barely underway. Techniques for genome editing are in their infancy, so are personalized medicine and the data-driven tools that can help track and manage individual health. The meatier questions of the health system, meanwhile—policies around who gets care and how it gets paid for—remain uncertain. How do you invest in this rapidly changing landscape? Where’s the smart money headed now? And where should health and tech companies themselves place their next big wagers? A roundtable discussion.
Yumin Choi, Managing Director, Bain Capital Ventures
Jennifer Fonstad, Co-Founder, Aspect Ventures
Ian Sigalow, Co-Founder and Partner, Greycroft
David Singer, Managing Partner, Maverick Ventures
Moderator: Michal Lev-Ram, Fortune
Photograph by Stuart Isett/Fortune
023
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:40 AM
HOW AI WILL CHANGE MEDICINE
The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.
Adrian Aoun, CEO and Founder, Forward
Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health
Julie Sweet, Chief Executive Officer, North America, Accenture
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
040
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
3:35 PM
WHY DON’T WE TALK ABOUT DEATH?
Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.
Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation
Michael Hebb, Founder, Death over Dinner
Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
035
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
1:00 PM
CONCURRENT LUNCH SOLUTION SESSIONS
PATIENT TRIALS WE CAN ACTUALLY LEARN FROM
Hosted by City of Hope
The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.
Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health
Matt de Silva, Co-Founder, CEO and Director, Notable Labs
Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator
Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
011
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
5:10 PM
PRECISION MEDICINE: WHERE IT’S WORKING AND WHY
The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.
Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School
Othman Laraki, Co-Founder and CEO, Color
Dr. Vijay Pande, General Partner, Andreessen Horowitz
Moderator: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
001
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
11:30 AM–1:00 PM
OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT
Hosted by PAREXEL
The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.
Dr. Udit Batra, CEO, MilliporeSigma
David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit
Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute
Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health
Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting
Photograph by Stuart Isett/Fortune
005
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
3:10 PM
THE BORDERLESS WORLD
If we’ve learned anything over past decades as we shape health care policy, it’s that the lines on the global map are thin and permeable, when they exist at all. From the spread of disease and emerging pathogens to the logistics of drug development and medical manufacturing, borders are increasingly irrelevant. We press some globally minded thinkers on how enterprises can manage the challenges of an increasingly connected planet—and better yet, tap the power of a connected world.
Joe Almeida, Chairman, President and CEO, Baxter International
George Barrett, Executive Chairman, Cardinal Health
Michael Milken, Chairman, Milken Institute
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
034
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
1:00 PM
CONCURRENT LUNCH SOLUTION SESSIONS
HEALTH CARE AND THE FOURTH INDUSTRIAL REVOLUTION
Hosted by Herman Miller
The industrial revolutions of yore heralded a transition from hand-powered production methods to machine-driven ones and the advent of mass production. The next industrial revolution is a decidedly digital one—and its implications for health care may be more significant than for any other industry. Far beyond telemedicine, the digital age isn’t just changing how we do medicine, but also how we define it. From the health gig economy to AI-run hospitals to on-demand diagnostics, technology is prompting a never-ending question: Where will this fourth revolution take us next?
Hema Budaraju, Product Lead, Health, Facebook
Sally Daub, CEO, Enlitic
Sajid Rahman, CEO, Telenor Health
Dr. Roy Schoenberg, President and CEO, American Well
Owen Tripp, Co-Founder and CEO, Grand Rounds
Moderator: Dr. David B. Agus, University of Southern California
Introduction: Mike O’Toole, Senior Vice President of Sales, Herman Miller
Photograph by Stuart Isett/Fortune
040
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
3:35 PM
WHY DON’T WE TALK ABOUT DEATH?
Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.
Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation
Michael Hebb, Founder, Death over Dinner
Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
001
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
11:30 AM–1:00 PM
OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT
Hosted by PAREXEL
The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.
Dr. Udit Batra, CEO, MilliporeSigma
David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit
Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute
Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health
Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting
Photograph by Stuart Isett/Fortune
025
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
10:45 AM
CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING
West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.
Dr. E. Gordon Gee, President, West Virginia University
Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University
Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
045
FORTUNE Brainstorm Tech
December 1st, 2021
Half Moon Bay, CA
2:50 PM
BEYOND THE SUPERCOMPUTER
Classical computing has changed the world with multiple revolutions in cloud, AI and Machine learning. But believe it or not, it’s reaching its peak. And so, the promise of Quantum technology is that it has the potential to truly help solve some of our greatest challenges - climate, supply chain shortages and inefficiencies, food insecurity, cyber vulnerabilities, and destabilization of economies. What will it take to really get there and how far are we anyway?
Speaker:
Pete Shadbolt, Co-founder and Chief Scientific Officer, PsiQuantum
Tony Uttley, President, Quantum Solutions, Honeywell
Moderator: Verne Kopytoff, FORTUNE
Photograph by Nick Otto for FORTUNE BRAINSTORM TECH
023
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:40 AM
HOW AI WILL CHANGE MEDICINE
The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.
Adrian Aoun, CEO and Founder, Forward
Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health
Julie Sweet, Chief Executive Officer, North America, Accenture
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
092023
Andi Lanuza
Brainstormer 4 - Vengeance for a Crime, Naval, Baker
Given three random words, we were tasked to come up with a piece that would contain these words. This is what I came up with.
So Bill, the baker, sends muffins to his former friend and his enemy now, Joe, who works at the navy. He poisons the muffins he sent him as revenge for the times Joe has stolen his muffins from his bakery a couple of years back.
038
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
2:55 PM
FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US
Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.
Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College
Photograph by Stuart Isett/Fortune
021
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:30 AM
THE POWER OF BEDSIDE DATA
A technology that monitors a person’s respiratory rate, heart rate and movement may not seem, at first, like much of an innovation—but consider that EarlySense does this by way of a sensor slipped under your mattress. That allows staff at anywhere from hospitals to nursing homes keep an electronic eye on non-critical patients’ vital signs—in a way that doesn’t have to be invasive. Princess and the Pea: Meet the digital age.
Dr. Karissa Price-Rico, COO, EarlySense Ltd.
Photograph by Stuart Isett/Fortune
023
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:40 AM
HOW AI WILL CHANGE MEDICINE
The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.
Adrian Aoun, CEO and Founder, Forward
Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health
Julie Sweet, Chief Executive Officer, North America, Accenture
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
025
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
10:45 AM
CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING
West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.
Dr. E. Gordon Gee, President, West Virginia University
Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University
Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
002
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:05 PM
SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT
The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.
The Fortune Brainstorm Health Co-Chairs:
Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health
Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health
Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
004
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:45 PM
MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM
Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.
Deborah DiSanzo, General Manager, IBM Watson Health
Amy Powell, President, Paramount Television and Digital Entertainment
Bernard J. Tyson, Chairman and CEO, Kaiser Permanente
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
014
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
7:00 PM–9:00 PM
DINNER AND FEATURED INTERVIEW
Hosted by IBM Watson Health
WELCOME
Deborah DiSanzo, General Manager, IBM Watson Health
THE SECRET TO TONY ROBBINS’ SUCCESS
He’s the go-to life and business strategist for high-octane CEOs, athletes, celebrities, and politicians. And, his empire of seminars, books, audio, video, and life training programs has empowered more than 50 million people from 100 countries who may not be lucky enough to have him on speed dial. Tony Robbins insists he can teach anyone to be confident, but where did the CEO Whisperer’s own strength come from? Fresh from another wildly popular “Unleash the Power Within” event, here’s Robbins as you’ve never seen him before. Joining us for an intimate interview in which he shares his own difficult personal upbringing, Robbins reveals how he went from homeless to household name—and how he can teach anyone else to believe in themselves.
Tony Robbins, Life and Business Strategist; Author, Unshakeable, Money: Master the Game
Interviewer: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
THE FUTURE OF IPOS
A long-anticipated stampede of unicorns rushing into the market has begun. Will this year’s jam-packed IPO calendar be a last hurrah for major market debuts? And will more upstarts follow the lead of Spotify and Slack in sidestepping underwriters through direct listings?
Joseph Mecane, Head of Execution Services, Citadel Securities
Leslie Pfrang, Partner, Class V Group
John Tuttle, Vice Chairman and Chief Commercial Officer, NYSE Group
Moderator: Robert Hackett, FORTUNE Photography by Rebecca Greenfield/Fortune
002
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:05 PM
SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT
The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.
The Fortune Brainstorm Health Co-Chairs:
Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health
Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health
Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
006
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
3:35 PM
IN DEFENSE OF SCIENCE
We live in a time of mind-boggling change and technological advance. Cars drive themselves. Robots perform surgery. Phones can probe the connections of the universe. And humans edit the molecular instructions that shape their very humanity. Yet even as we hurtle through this futuristic present, swept up in discovery and innovation, a surprisingly powerful force is pushing back from the horizon: the fear of science. That force has rallied to challenge the foundation of science itself, undermining scientific research—and, yes, public health and safety. Now, more than ever, the field requires investment and talent, both of which are imperiled. How can we most effectively respond to this assault? What can be done to restore trust in science and fact? And how can we promote investment in science, and draw a new generation of enterprising thinkers to the field?
Dr. Susan Desmond-Hellmann, Chief Executive Officer, Bill & Melinda Gates Foundation
Dr. Margaret Hamburg, President, American Association for the Advancement of Science
Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine
Moderator: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
004
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:45 PM
MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM
Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.
Deborah DiSanzo, General Manager, IBM Watson Health
Amy Powell, President, Paramount Television and Digital Entertainment
Bernard J. Tyson, Chairman and CEO, Kaiser Permanente
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
003
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:20 PM
U.S. HEALTH CARE: AT THE CROSSROADS
A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.
Mark Bertolini, Chairman and CEO, Aetna Inc.
Interviewer: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
022
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:35 AM
CAN A MACHINE STAFF YOUR HOSPITAL?
It has been called the great mismatch: legions of applicants for today’s 21st-century jobs aren’t prepared for the many positions available; meanwhile tens of thousands of talented people aren’t getting to put their skills to use—and the challenge is particularly acute in the health care economy. Meet the founder of one startup who believes she has the solution: using machine learning to find people with the traits most likely to make them great performers.
Kristen Hamilton, CEO and Co-founder, Koru
Photograph by Stuart Isett/Fortune
026
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
11:10 AM
A MOTHER FIGHTS BACK: USING BIG DATA AND GENOMICS TO SILENCE HER SON’S KILLER
Theresa Beech’s 13-year-old son Daniel died nearly two years ago from osteosarcoma. Daniel’s killer: a pediatric bone cancer whose treatment—and survival rates—haven’t changed in 30 years. But the time for change is now. Driven by the hope that she can spare other families this same pain and loss, Theresa — a space engineer by day — has collected the genetic codes from more than 100 young patients whose parents donated the data. What she has discovered offers hope for progress at last. The unbelievable story of one woman’s race to cure a terrible cancer.
Theresa Beech, President, Because of Daniel
Photograph by Stuart Isett/Fortune
001
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
11:30 AM–1:00 PM
OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT
Hosted by PAREXEL
The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.
Dr. Udit Batra, CEO, MilliporeSigma
David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit
Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute
Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health
Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting
Photograph by Stuart Isett/Fortune
092032
Jenny Lapus
Brainstormer 5 - Conviction, Klondike, Clock
This is an advertisement for the Flava Flav Klondike Collection. There is a testimonial from a man named Henry who has a strong conviction that this deck of cards is "WONDERFULL!!!!!!1111"
(I chose to feature Flava Flav on the cards because he is a celebrity famous for his huge clock necklaces)
023
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:40 AM
HOW AI WILL CHANGE MEDICINE
The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.
Adrian Aoun, CEO and Founder, Forward
Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health
Julie Sweet, Chief Executive Officer, North America, Accenture
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
031
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
12:30 PM
HOW TO CHANGE THE COURSE OF A DISEASE
It’s the last frontier: the human brain. When it comes to medical treatment, the brain and central nervous system remain the darkest, most forbidding, realm—even as our knowledge of how the brain and mind work grows by leaps each year. Now, some say we are at the edge of genuine breakthroughs in treatment for diseases that have haunted humankind for generations, from Huntington’s to ALS to Alzheimer’s. Two warriors on the front lines of brain science will share the latest discoveries and discuss what it will take to solve the most complex puzzles of our most complex organ.
Ann Romney, Global Ambassador, Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital
Dr. Rudolph Tanzi, Vice Chair of Neurology and Director, Genetics and Aging Research Unit, Massachusetts General Hospital; Professor of Neurology, Harvard Medical School
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
014
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
7:00 PM–9:00 PM
DINNER AND FEATURED INTERVIEW
Hosted by IBM Watson Health
WELCOME
Deborah DiSanzo, General Manager, IBM Watson Health
THE SECRET TO TONY ROBBINS’ SUCCESS
He’s the go-to life and business strategist for high-octane CEOs, athletes, celebrities, and politicians. And, his empire of seminars, books, audio, video, and life training programs has empowered more than 50 million people from 100 countries who may not be lucky enough to have him on speed dial. Tony Robbins insists he can teach anyone to be confident, but where did the CEO Whisperer’s own strength come from? Fresh from another wildly popular “Unleash the Power Within” event, here’s Robbins as you’ve never seen him before. Joining us for an intimate interview in which he shares his own difficult personal upbringing, Robbins reveals how he went from homeless to household name—and how he can teach anyone else to believe in themselves.
Tony Robbins, Life and Business Strategist; Author, Unshakeable, Money: Master the Game
Interviewer: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune